Hong Kong stocks movement | Trump predicts pharmaceutical tariffs, with pharmaceutical stocks generally declining. HBM HOLDINGS-B (02142) fell more than 7%.

Pharmaceutical stocks generally declined in the morning session. As of the time of writing, HBM HOLDINGS-B (02142) fell 7.06% to 8.04 Hong Kong dollars; JUNSHI BIO (01877) fell 6.38% to 14.98 Hong Kong dollars; REMEGEN (09995) fell 6.48% to 38.25 Hong Kong dollars.

Zhitong Finance23:50 ET

HBM HOLDINGS-B (02142) granted 4.875 million stock options.

HBM HOLDINGS-B (02142) announced that on April 29, 2025, according to the company's Shareholders in 2020...

Zhitong FinanceApr 29 10:11 ET

HBM HOLDINGS-B: Annual Report 2024

HKEXApr 22 10:13 ET · Announcements

Hong Kong stocks fluctuated | Pharmaceutical stocks generally declined as the Trump administration launched an investigation into pharmaceuticals, but Institutions remain Bullish on the growth potential of Innovative Drugs.

Pharmaceutical stocks generally fell. As of the time of writing, ASCLETIS-B (01672) dropped 12.64%, trading at 5.46 Hong Kong dollars; ALPHAMAB-B (09966) fell 7.74%, trading at 6.44 Hong Kong dollars; HBM HOLDINGS-B (02142) decreased by 7.31%, trading at 7.1 Hong Kong dollars.

Zhitong FinanceApr 15 23:24 ET

Hong Kong stocks have fluctuated | The Innovative Drugs Concept has seen significant gains. Institutions state that there is no need to pay tariffs on the licensing fees for Innovative Drugs, and support policies for Innovative Drugs are expected to be gr

The Innovative Drugs Concept has seen significant growth, as of the time of reporting, LAEKNA-B (02105) is up 13.16%, priced at 12.04 Hong Kong dollars; BRII-B (02137) is up 12.35%, priced at 1.82 Hong Kong dollars; CSTONE PHARMA-B (02616) is up 10.88%, priced at 2.65 Hong Kong dollars; BEIGENE (06160) is up 8.27%, priced at 148 Hong Kong dollars; HBM HOLDINGS-B (02142) is up 7.41%, priced at 7.68 Hong Kong dollars.

Zhitong FinanceApr 14 03:38 ET

Hong Kong stock market fluctuation | The Innovative Drugs Concept shows strong performance. Lepu Biotech-B (02157) rises over 18% and LAEKNA-B (02105) rises over 16%.

The Innovative Drugs Concept has shown strong performance. As of the time of writing, Lepu Biopharma-B (02157) is up 18.13%, trading at 4.3 Hong Kong dollars; LAEKNA-B (02105) is up 16.74%, trading at 10.88 Hong Kong dollars; AKESO (09926) is up 11.6%, trading at 82.75 Hong Kong dollars.

Zhitong FinanceApr 11 03:29 ET